Literature DB >> 24332506

High-dose itraconazole as a noncastrating therapy for a patient with biochemically recurrent prostate cancer.

Daniel L Suzman1, Emmanuel S Antonarakis2.   

Abstract

Entities:  

Keywords:  Biochemical recurrence; Hedgehog pathway; Itraconazole; Prostate cancer

Mesh：

Substances：

Year:  2013        PMID： 24332506      PMCID： PMC3959234          DOI： 10.1016/j.clgc.2013.11.015

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  9 in total

Review 1.  Hedgehog signaling in animal development: paradigms and principles.

Authors:  P W Ingham; A P McMahon
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth.

Authors:  James Kim; Jean Y Tang; Ruoyu Gong; Jynho Kim; John J Lee; Karl V Clemons; Curtis R Chong; Kris S Chang; Mark Fereshteh; Dale Gardner; Tannishtha Reya; Jun O Liu; Ervin H Epstein; David A Stevens; Philip A Beachy
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

3.  Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.

Authors:  H W Herr; M O'Sullivan
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

4.  Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Matthew R Smith
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

5.  Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.

Authors:  E J Small; A D Baron; L Fippin; D Apodaca
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

6.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.

Authors:  Pilar Sanchez; Ana Maria Hernández; Barbara Stecca; Andrea J Kahler; Amy M DeGueme; Andrea Barrett; Mercedes Beyna; Milton W Datta; Sumana Datta; Ariel Ruiz i Altaba
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

Authors:  Emmanuel S Antonarakis; Elisabeth I Heath; David C Smith; Dana Rathkopf; Amanda L Blackford; Daniel C Danila; Serina King; Anja Frost; A Seun Ajiboye; Ming Zhao; Janet Mendonca; Sushant K Kachhap; Michelle A Rudek; Michael A Carducci
Journal:  Oncologist       Date:  2013-01-22

8.  Hedgehog signalling in androgen independent prostate cancer.

Authors:  Greg Shaw; Anna M Price; Elena Ktori; Isabelle Bisson; Patricia E Purkis; Siobhan McFaul; R Tim D Oliver; David M Prowse
Journal:  Eur Urol       Date:  2008-02-04       Impact factor: 20.096

9.  Activation of the hedgehog pathway in advanced prostate cancer.

Authors:  Tao Sheng; Chengxin Li; Xiaoli Zhang; Sumin Chi; Nonggao He; Kai Chen; Frank McCormick; Zoran Gatalica; Jingwu Xie
Journal:  Mol Cancer       Date:  2004-10-13       Impact factor: 27.401
  9 in total
  6 in total

1.  Repurposing itraconazole for the treatment of cancer.

Authors:  Rachel Pounds; Sarah Leonard; Christopher Dawson; Sean Kehoe
Journal:  Oncol Lett       Date:  2017-07-10       Impact factor: 2.967

2.  Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.

Authors:  Pan Pantziarka; Vidula Sukhatme; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2015-04-15

Review 3.  Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer.

Authors:  Daniel L Suzman; Emmanuel S Antonarakis
Journal:  Cancers (Basel)       Date:  2015-09-29       Impact factor: 6.639

4.  Itraconazole inhibits the proliferation of gastric cancer cells in vitro and improves patient survival.

Authors:  Ke Lan; Ron Yan; Kun Zhu; Wenhan Li; Zisen Xu; Chengxue Dang; Kang Li
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

5.  Inhibition of the hedgehog pathway for the treatment of cancer using Itraconazole.

Authors:  Ke Li; Dengyang Fang; Zuming Xiong; Runlan Luo
Journal:  Onco Targets Ther       Date:  2019-08-23       Impact factor: 4.147

6.  CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.

Authors:  Richard E Kast; Georg Karpel-Massler; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2014-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.